Skip to main content

Biobuzz Directory – Intrexon Signs $100Mm Deal with Surterra Wellness to Advance Commercial Scale Cannabinoid Production

By June 24, 2019News
intrexon-surterra-logo

intrexon-surterra-logo

Intrexon has scaled its proprietary yeast fermentation process and is on track to realize production of pure cannabinoids at a target cost of goods of <$1,000/kg. With exclusive global access to Intrexon’s technology for microbial production of cannabinoids, Surterra gains a clear research and development roadmap to:

Surterra Wellness

{iframe}https://biobuzz.inloop.com/en/article/72276?utm_source=ElasticEmail-sb-biobizHub&utm_medium=newsletter&utm_campaign=biobizHub-601-s-en-190619&itd_did=601&itd_uid=3432{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.